A multicenter cohort study of patients with obesity suggests a decreased risk of developing new obesity-related cancers in patients with a history of bariatric surgery.
Nuclear Renal Scans No Longer Needed to Calculate Split Renal Function in Patients with Kidney Tumors
Study is the first to convincingly show the utility of parenchymal volume analysis in calculating split renal function in patients with renal masses considering radical nephrectomy.
Two Years Later: Progress in the Genitourinary Malignancies Research Center
Androgen-receptor (AR) antagonists can alter the metabolism of patients with prostate cancer, shows a recent study. And a transporter protein may become a new therapeutic target for kidney cancer.
Survival Rates Higher for Patients with Metastatic Renal Cancer at High-Volume Facilities
This study establishes the volume-outcome association for metastatic renal cell carcinoma. High volume centers come out on top.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
IMmotion Update: Understanding the Biomarkers Behind Better Outcomes
Patients with metastatic renal cell carcinoma respond better to combined atezolizumab and bevacizumab vs sunitinib alone. New biomarker data explain why.
New Center Aims to Produce Practice-Changing Discoveries in Genitourinary Cancer
Recruitment underway to bring additional leading scientists to expanding GU cancer research program at Cleveland Clinic.
Phase 3 Study Tests a New Combination Therapy for Metastatic Renal Cell Cancer
This randomized phase 3 study compared treatment with sunitibib with a combination therapy of the anti-VEGF drug bevacizumab and atezolizumab, an engineered monoclonal antibody against PD-L1.
Follow-up Care for Renal Mass Patients Requires Attention to Both Kidney Function and Cancer Recurrence
After partial nephrectomy, urologists find there’s still much follow-up work to do — from monitoring kidney function to cancer surveillance. What are the best methods for both?
Immunotherapies Show Promise Against Some Metastatic Cancers
Two studies show that a new combination immunotherapy regimen can produce remission in some patients and improve survival in metastatic melanoma and kidney cancer.
Precise Renal Function Testing Helps Post-Nephrectomy Management
Accurate renal function measurement is critical to predict long-term adverse outcomes after nephrectomy. The relationship between chronic kidney disease and poor clinical outcomes is robust, but prediction can be improved by incorporating proteinuria.